Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Travoprost, Fractional CO2 Laser, and Excimer Light in Vitiligo
NCT04577027Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 4, open-label trial of travoprost in Vitiligo (6 arms), sponsored by Assiut University. Primary endpoint: Vitiligo Area Scoring Index at 9 months. Status: unknown.
02
Drugs
travoprost
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04577027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04577027.